Redeye updates its view and outlook on Nanologica following the company’s year-end report and announcement of a fully guaranteed rights issue. We make minor revisions to our estimates and adjust our valuation for the dilution, leading to a new fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Nanologica Q4 2023 - Strong outlook for 2024

© Modular Finance, source Nordic Press Releases